Healthcare -
Biotechnology - NASDAQ - US
$ 1.53
-0.649 %
$ 4.88 M
Market Cap
-0.13
P/E
MBRX - CAPITAL EXPENDITURES
Capital Expenditures MBRX - Moleculin Biotech, Inc.
-124 K
LAST VALUE
-155.47%
2 YEAR CAGR
21.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR